The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Cinacalcet stUdy for Peritoneal Dialysis Patients In Double Arm on the Lowing Effect OF iPTH Level
Official Title: Phase 4 Study of Cinacalcet Efficacy in Combination With Vitamin D for the Treatment of Secondary Hyperparathyroidism in Peritoneal Dialysis Patients
Study ID: NCT01101113
Brief Summary: This study is designed in order to investigate the effect of cinacalcet in combination with routine conventional medical management for treatment of secondary hyperparathyroidism (SHPT) and Ca, P control. This study will compare the efficacy of a cinacalcet-based regimen with unrestricted conventional care (vitamin D and phosphate binders) for achieving the stringent National Kidney Foundation Kidney Disease Outcomes Quality Initiative (KDOQI) targets for dialysis patients.
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Seoul National University Hospital, Seoul, Korea, Korea, Republic of
Kyungpook National University, Daegu, , Korea, Republic of
Gil Hospital, Incheon, , Korea, Republic of
Hallym University Sacred Hospital, Pyungchon, , Korea, Republic of
Seoul National University Bundang Hospital, Seongnam, , Korea, Republic of
Eulji University, Seoul, , Korea, Republic of
Samsung Medical Center, Seoul, , Korea, Republic of